Your complete medical history should be reviewed, including: Previous or current mental health conditions and their treatment history If an eating disorder is suspected or active, seek specialist assessment
"These findings highlight the urgent need for evidence-based guidance for when GLP-1RAs should be used relative to bariatric surgery in adolescents and young adults, including whether medications are most effective before surgery, after surgery, or as part of combination therapy." The findings were reported in the paper, GLP-1 Receptor Agonist and Bariatric Surgery Utilization Among Adolescents and Young Adults, published in JAMA Pediatrics
3 Targets Stubborn Visceral Fat GLP-1 therapy is clinically proven to reduce visceral fat, the deep abdominal fat linked to heart disease, insulin resistance, and metabolic syndrome, measured precisely through DEXA scans at baseline and throughout your program
Results guide PlexusDx clinicians in personalizing your dose, choosing between monotherapy and dual-compound options, and predicting which patients benefit most from GLP-1 treatment
When to Contact Your Prescriber Self-injection technique issues that warrant a clinical call include: a lump or hardened area at the injection site that persists for more than 2 weeks (possible lipohypertrophy), signs of infection (expanding redness, warmth, pus, or fever), allergic reaction at the site (hives, intense itching, or swelling beyond 2 inches), and any systemic symptoms such as severe abdominal pain, persistent vomiting, or signs of pancreatitis
